CRISPR Therapeutics and Vertex Present New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at American Society of Hematology Annual Meeting and Exposition, Together With Publication in the New England Journal of Medicine

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy